Fallopian Tube Cancer; Starts in the Fallopian Tubes, Which Connect Woman's Ovaries to Their Uterus

Fallopian Tube Cancer
Fallopian Tube Cancer

Fallopian Tube Cancer, or tubal cancer, develops in the fallopian tubes that connect the ovaries and the uterus. It is a very rare cancer and accounts for only 1 to 2% of all gynecologic cancers. Most stage I ovarian/fallopian tube cancer are clear cell, endometrioid, and mucinous with only small percent being high-grade serous cancers. While most advanced-stage ovarian cancer are high-grade serous cancers. Fallopian tube cancer affects the duct (tube) that carries eggs from the ovaries to the uterus.

Fallopian Tube Cancer Market develops at the end of a fallopian tube where eggs enter from an ovary. The cancer then spreads to the surface of the ovary. It can also recur in another part of the body. The main treatments are surgery and chemotherapy. Surgery, followed by chemotherapy, is the main treatment for fallopian tube. However, the treatment depends on the stage of the cancer. Fallopian tubes, cervix, uterus, and ovaries, as well as nearby lymph nodes, are usually removed during the surgical procedure(s).

Depending on the size, location, and stage of the cancer, an individual may undergo a surgical procedure to remove the affected tube and adjacent ovary. Recurrent cancer means that the cancer has come back after it has been treated. If it comes back in the same place the cancer first started or close to where it started, it's called local recurrence. The 2 tests used most often (in addition to a complete pelvic exam) to screen for ovarian cancer are transvaginal ultrasound (TVUS) and the CA-125 blood test.

CA125 is a blood test that checks levels of a blood protein known as CA125, a gold standard tumor marker in ovarian cancer. Fallopian Tube Cancer is the rarest cancer to affect the female reproductive system (gynecological cancer). More than 1,500 to 2,000 cases of fallopian tube cancer have been reported worldwide, and around 300 to 400 women are diagnosed with the condition annually in the United States.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care

Image
Patient-Centered Medical Home The Patient-Centered Medical Home is a care model in which individuals are involved in a direct association with a chosen physician who organizes a supportive team of hospital experts, takes cooperative accountability for the comprehensive incorporated care offered to the patient, and sponsors and arranges suitable care with other professional physicians and community sources as per requirements. Use of PCMH develop disciplinary care teams to enhance care management and care administration of patient populaces focusing to increase safety, efficacy and standard in patient care. PCMH practices can enhance care and take benefits of private or public inducement payments that are offered to patients. The Patient Protection and Affordable Care Act (ACA) provides extra federal expenditure to regions for health homes helping Medicaid receivers. Supplier groups and hospitals can visit their federal and state officials and private insurers’ websites for data on exp
Read more